Literature DB >> 16394499

Inhibitory effects of polyphenols on p-glycoprotein-mediated transport.

Shuji Kitagawa1.   

Abstract

Overexpression of P-glycoprotein (P-gp), a plasma membrane transporter which extrudes chemotherapeutic agents out of cells, has been associated with the multidrug resistance (MDR) of cancer cells. It has been revealed that flavonoids and other polyphenols inhibit P-gp activity. Due to their inhibitory activities of polyphenols on P-gp function and their physiological safety, they are possible candidates for modulators of MDR. To determine suitable candidates, it is important to clarify the structure-activity relationships of their inhibitory activities on P-gp function. Determining the structure-activity relationships is also meaningful because the intake of dietary polyphenols may also alter drug pharmacokinetics and pharmacodynamics via inhibition of P-gp-mediated drug efflux in tissues such as the intestinal epithelium, blood-brain barrier, hepatocytes and renal tubular cells. This is a review of our recent investigations using multidrug-resistant P-gp overexpressing KB-C2 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16394499     DOI: 10.1248/bpb.29.1

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  12 in total

1.  Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells.

Authors:  Hao Li; Lulu Hui; Wenlin Xu; Huiling Shen; Qiaoyun Chen; Lulu Long; Xiaolan Zhu
Journal:  Oncol Lett       Date:  2011-11-30       Impact factor: 2.967

Review 2.  Effects of anthocyanins on the prevention and treatment of cancer.

Authors:  Bo-Wen Lin; Cheng-Chen Gong; Hai-Fei Song; Ying-Yu Cui
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

3.  Dietary flavonoids modulate CYP2C to improve drug oral bioavailability and their qualitative/quantitative structure-activity relationship.

Authors:  Hong-Jaan Wang; Li-Heng Pao; Cheng-Huei Hsiong; Tung-Yuan Shih; Meei-Shyuan Lee; Oliver Yoa-Pu Hu
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

4.  Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.

Authors:  A Dreiseitel; B Oosterhuis; K V Vukman; P Schreier; A Oehme; S Locher; G Hajak; P G Sand
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

5.  Naringenin enhances the anti-tumor effect of doxorubicin through selectively inhibiting the activity of multidrug resistance-associated proteins but not P-glycoprotein.

Authors:  Fa Yun Zhang; Gang Jun Du; Ling Zhang; Chun Ling Zhang; Wan Liang Lu; Wei Liang
Journal:  Pharm Res       Date:  2008-12-10       Impact factor: 4.200

Review 6.  Food and Drug Interactions.

Authors:  Jong Hwan Choi; Chang Mann Ko
Journal:  J Lifestyle Med       Date:  2017-01-31

7.  GALNT14 Involves the Regulation of Multidrug Resistance in Breast Cancer Cells.

Authors:  Jinshuai Shan; Yang Liu; Yukun Wang; Yimiao Li; Xiaochun Yu; Chen Wu
Journal:  Transl Oncol       Date:  2018-04-24       Impact factor: 4.243

8.  The effect of resveratrol on the expression of MDR1 gene in leukemic lymphoblast's of acute lymphoblastic leukemia patients.

Authors:  Abbas Ali Hosein Poor Feyzi; Majid Farshdousti Hagh; Tohid Ebadi; Karim Shams Asanjan; Aliakbar Movasagpoor Akbari; Mehdi Talebi; Behzad Emadi
Journal:  Caspian J Intern Med       Date:  2015

Review 9.  South Asian Medicinal Compounds as Modulators of Resistance to Chemotherapy and Radiotherapy.

Authors:  N Rajendra Prasad; Ganesan Muthusamy; Mohana Shanmugam; Suresh V Ambudkar
Journal:  Cancers (Basel)       Date:  2016-03-05       Impact factor: 6.639

Review 10.  Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds.

Authors:  Lalita Guntuku; V G M Naidu; Veera Ganesh Yerra
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.